| 早产治疗新进展 |
| |
| 引用本文： | 赵云红,甘泉.早产治疗新进展[J].大理学院学报,2004,3(5):95-97. |
| |
| 作者姓名： | 赵云红 甘泉 |
| |
| 作者单位： | 武警云南总队医院妇产科,云南昆明,650111 |
| |
| 摘 要： | 目的 :综述早产治疗的新进展。方法 :检索大量国内外文献 ,综合归纳。结果 :一种抑制宫缩的新药———催产素受体拮抗剂依保(atosiban)是一种有效的、副反应较少的、具有广泛临床应用前景的治疗早产的药物。结论 :Atosiban是一种值得产科医生期待的治疗早产的新药。
|
| 关 键 词： | 早产 催产素受体拮抗剂 β受体激动剂 |
| 文章编号： | 1672-2345(2004)05-0095-03 |
| 修稿时间： | 2003年12月30 |
Development in Treatment of Preterm Dirth |
| |
| ZHAO Yun- hong,GAN Quan.Development in Treatment of Preterm Dirth[J].Journal of Dali University,2004,3(5):95-97. |
| |
| Authors: | ZHAO Yun- hong GAN Quan |
| |
| Abstract: | Preterm birth is one of common complications,and is major cause of perinatal mortality and morbidity in obstetric.The recent introduction of the oxytocin antagonist,atosiban,represents a new Effective and safe drug of the uterotonic antagonist in treatment of preterm birth.The aim of this review is to discuss the reasons of preterm labor and development in treatment of preterm birth. |
| |
| Keywords: | Preterm labor Atosiban |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
